Program and abstracts (PDF file available at the end of this page)

Symposium I: Monday October 22, 10:00 – 12:00

Edward O’Brien MD FRCPC FAHA FACC, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada: Modulating estrogen receptor beta and atherosclerosis.
Philip Shaul MD, Department of Pediatrics, UT Southwestern Medical Center, Dallas, Texas, USA: New ligands and protein-protein interactions for an old receptor.
Ellis Levin MD, Department of Biochemistryand Pharmacology, Irvine and the Long Beach VA Medical Center, University of California, California, USA: Estrogen signaling to prevent cardiovascular disease.

Marc Ruel MD MPH FRCSC, (NEW SPEAKER, see abstract below) University of Ottawa, Ottawa, Canada; Efficacy issue and therapy monitoring in cardiac cell-based regeneration.
Qingbo Xu MD PhD, Cardiovascular Division, The James Black Centre, Kings College, London: Role of stem cells in vascular repair.
Charles E. Murry MD PhD, Center for Cardiovascular Biology, University of Washington, Washington, USA; Repairing the infarcted heart: Roles for endogenous and exogenous stem cells.

Robert Hegele MD FRCPC FACP, Robarts Research Institute, University of Western Ontario, London, Ontario: Riding the phenotypic bell curve and testing genes for holes: the search for genetic determinants of metabolic risk factors.
Jacques Genest MD FRCPC, Division of Cardiology, McGill University Health Center, Montréal, Québec, Canada: Genetics of HDL.
Shailesh B. Patel BM ChB Dphil FRCP, Division of Endocrinology, Metabolism and Clinical Nutrition, Medical College of Wisconsin, Miwaukee, Wyoming, USA: Rare sterol disorders and insights?.

Xiao-Yan Wen PhD, McLaughlin Center for Molecular Medicine, University of Toronto, Toronto, Ontario, Canada: Roles of two novel phospholipases A1 (lpdl and lpdlr) in lysophos^hatidic acid (LPA) generation and thrombosis.